Serum β2-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 439-447

  Hallek, Michael ^a   Wanders, Lioba ^a   Ostwald, Marianne ^a   Busch, Raymonde ^b   Senekowitsch, Reingard ^b   Stern, Sieglinde ^a   Schick, Hans Dieter ^b   Kuhn Hallek, Ingrid ^a   Emmerich, Bertold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chronic lymphocytic leukemia; Immunocytoma; Progression free survival; Serum thymidine kinase; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; HEMOGLOBIN; THYMIDINE KINASE;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; IMMUNOCYTOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

EID: 0029829395     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054782     Document Type: Article

References (63)

1. Lennert, K. and Feller, A. C. (1990) Histopathologie der Non-Hodgkin-Lymphome (nach der aktualisierten Kiel-Klassifikation). Berlin, Springer-Verlag.
2. Stansfeld, A. G., Diebold, J., Kapanoi, Y., Kelény, G., Lennert, K., Mioduszewska, O., Noel, H., Rilke, F., Sundstrom, C., van Unnik, J. A. M. and Wright, D. H. (1988) Updated Kiel classification for lymphomas. Lancet, i, 292-293.
3. Lennert, K., Mohri, N., Stein, H. and Kaiserling, E. (1975) The histopathology of malignant lymphoma. Br. J. Haematol., 31, 193-203.
4. Longo, D. L., De Vita jr, V. T., Jaffe, E. S., Mauch, P. and Urba, W. J. (1993) Lymphocytic lymphomas. In: De Vita jr, V. T., Hellman, S. and Rosenberg, S. A. (ed): Cancer: Principles & Practice of Oncology. Philadelphia, J. B. Lippincott Co., p 1859-1927.
5. Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasgucn, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchemia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M. T., Monconduit, M., Belabbes, S. and Gremy, F. (1981) A new prognostic classification of chronic lymphatic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-204.
6. Rai, K., Sawitsky, A., Cronkite, E., Chanana, A. B., Lee, R. N. and Pastemack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
7. International Workshop on Chronic Lymphocytic Leukemia (1989) Chronic lymphocytic leukemia: Recommendations for diagnosis, staging and response criteria. Ann. Intern. Med., 110, 236-238.
8. Dillman, R. O., Mick, R. and McIntyre, O. K. (1989) Pentostatin in chronic lymphocytic leukemia: A phase II trial of cancer and leukemia group B. J. Clin. Oncol. 7, 433-438.
9. Keating, M. J., Kantarjian, H., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E. J. and McCredie, K. B. (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood, 74, 19-25.
10. Cheson, B. (1992) The purine analogs - a therapeutic beauty contest. J. Clin. Oncol., 10, 352-355.
11. Piro, L. D., Carrera, C. J., Beutler, E. and Carson, D. A. (1988) Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lympocytic leukemia. Blood, 72, 1069-73.
12. Ziegler-Heitbrock, H. W. L., Schlag, R., Flieger, D. and Thiel, E. (1989) Favorable response of early response B-CLL patients to treatment with IFN-alpha. Blood, 73, 1426-1430.
13. Pangalis, G. A. and Griva, E. (1988) Recombinant alpha-2b interferon in untreated stages A and B chronic lymphocytic leukemia: a preliminary report. Cancer, 61, 869-872.
14. Roth, M. S. and Foon, K. A. (1986) Alpha interferon in the treatment of hematologic malignancies. Am. J. Med., 67, 216-220.
15. Rozman, C., Montserrat, E., Vinolas, N., Urbano-Ispizua, A., Ribera, J. M., Gallart, T. and Compernolle, C. (1988) Recombinant alpha-interferon in the treatment of B chronic lymphocytic leukemia in early stages. Blood, 71, 1295-1298.
16. Foon, K. A., Sherwin, S. A., Abrams, P. G. and Al, E. (1984) Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. N. Engl. J. Med., 311, 1148-1152.
17. Bandini, G., Michallet, M., Rosti, M. and Tura, S. (1991) Bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant, 7, 101-103.
18. Bandini, G. and Michallet, M. (1992) High-dose therapy and allogeneic bone marrow transplantation in chronic lymphocytic leukemia. In: Armitage, J. O. and Antman, K. H. (ed): High-dose cancer therapy. Pharmacology, hematopoietins, stem cells. Baltimore, Williams & Wilkins, p 626-637.
19. Rabinowe, S. N., Soiffer, R. J., Gribben, J. G., Daley, H., Freedman, A. S., Daley, J., Pesek, K., Neuberg, D., Pinkus, G., Leavitt, P. R., Spector, N. A., Grossbard, M. L., Anderson, K., Robertson, M. J., Mauch, P., Chayt-Marcus, K., Ritz, J. and Nadler, L. M. (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood, 82, 1366-1376.
20. Khouri, I. F., Keating, M. J., Vriesendorp, H. M., Reading, C., Przepiorka, D., Huh, Y. O., Andersson, B. S., van Besien, K. W., Mehra, R. C., Giralt, S. A., Ippoliti, C., Marshall, M., Thomas, M. W., O'Brien, S., Robertson, L. E., Deisseroth, A. B. and Champlin, R. E. (1994) Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J. Clin. Oncol. 12, 748-758.
21. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., Binet, J. L. and The French Cooperative Group on CLL (1991) B-cell chronic lymphocytic leukemia: present status and future directions. Blood, 78, 1901-1914.
22. Foon, K. A., Rai, K. R. and Gale, R. P. (1990) Chronic lymphocytic leukemia: new insights into biology and therapy. Ann. Intern. Med., 113, 525-539.
23. Rozman, C. and Montserrat, E. (1989) Chronic lymphocytic leukaemia: when and how to treat. Blut, 59, 467-474.
24. Molica, S. (1991) Progression and survival studies in early chronic lymphocytic leukemia. Blood, 78, 895-9.
25. Rai, K. R. and Rabinowe, S. N. (1993) Chronic lymphocytic leukemia. In: Holland, J. F., Frei III, E., Bast jr, R. C., Kufe, D. W., Morton, D. L. and Weichselbaum, R. R. (ed): Cancer Medicine. Philadelphia, Lea & Febiger, p 1971-1988.
26. Engelhard, M., Brittinger, G., Heinz, R., Theml, H., Bartels, H., Binder, T., Fülle, H. H., Gerhartz, H., Gunzer, U., Ludwig, F., Ludwig, W. D., Nowicki, L., Oertel, J., Pees, H. W., Pralle, H., Rühl, U., von Schilling, C., Spann, W., Stacher, A., Szeimies, U., Wetzel, H. J., Zwingers, T., Feller, A. C., Stein, H. and Lennert, K. (1993) Chronic lymphocytic leukemia (B-CLL) and immunocytoma (LP-IC): clinical and prognostic relevance of this distinction. Leuk. Lymphoma, Suppl., 161-173.
27. Facon, T., Brouillard, M., Duhamel, A., Morel, P., Simon, M., Jouet, J. P., Bauters, F. and Fenaux, P. (1993) Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases. J. Clin. Oncol. 11, 1553-1558.
28. Gobbi, P. G., Bettini, R., Montencucco, C., Cavanna, L., Morandi, S., Pieresca, C., Merlini, G., Bertolini, D., Grignani, G., Pozzetti, U., Caporali, R. and Ascari, E. (1994) Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood, 83, 2939-2945.
29. Ellims, P. H., Eng Gan, T., Medley, G. and van der Weyden, M. B. (1981) Prognostic relevance of thymidine kinase in adult nonHodgkin's lymphoma. Blood, 58, 926-930.
30. Gronowitz, J. S., Hagberg, H., Källander, C. F. R. and Simonsson, B. (1983) The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Br. J. Cancer, 47, 487-495.
31. Hagberg, H., Glimelius, B., Gronowitz, J. S., Killander, A., Källander, C. F. R. and Schröder, T. (1984) Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis. Scand. J. Haematol., 33, 59-67.
32. Hallek, M., Emmerich, B., Strohmeyer, S., Busch, R., Reichle, A. and Senekowitsch, R. (1988) Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors. Klin. Wochenschr., 66, 718-723.
33. Hallek, M., Schick, H. D., Busch, R., Strohmeyer, S., Wanders, L. and Emmerich, B. (1990) Serum thymidine kinase in low and intermediate grade non-Hodgkin's lymphoma. Folia Oncol., 13, 87-91.
34. Hallek, M., Wanders, L., Schick, H. D., Busch, R., Senekowitsch, R., Emmerich, B. and Rastetter, J. (1990) Factors predicting the risk of progression in low and intermediate grade non-Hodgkin's lymphoma (NHL): a multivariate analysis (abstr.). Proc. Am. Soc. Clin. Oncol., 9, 272.
35. Källander, C. F. R.;, Simonsson, B., Hagberg, H. and Gronowitz, J. S. (1984) Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia. Cancer, 54, 2450-2455.
36. Martinsson, U., Glimelius, B., Hagberg, H. and Sundstrom, C. (1988) Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas. Eur. J. Haematol., 40, 289-98.
37. Martinsson, U., Glimelius, B., Hagberg, H. and Sundstrom, C. (1989) Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival. Eur. J. Haematol., 43, 332-8.
38. Simonsson, B., Wibell, L. and Nilsson, K. (1980) α2-microglobulin in chronic lymphocytic leukaemia. Scand. J. Haematol., 24, 174-180.
39. Simonsson, B., Brenning, G., Kallander, C. and Ahre, A. (1987) Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma. Eur. J. Clin. Invest., 17, 336-9.
40. Späti, B., Child, J. A., Kerruish, S. M. and Cooper, E. H. (1980) Behaviour of serum ß2-microglobulin and acute phase reactant protein in chronic lymphocytic leukemia. Acta haemat., 64, 79-86.
41. Knospe, W.H., Loeb, jr, V. and Huguley jr, CM. (1974) Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer, 33, 555-562.
42. Bagley, C. M., De Vita jr, V. T., Berard, C. W. and Canellos, G. P. (1972) Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann. Intern. Med., 76, 227-234.
43. Karnofsky, D. A., Abelman, W. H., Craver, L. F. and Burchenal, J. H. (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer, 1, 634-639.
44. Gronowitz, J. S., Hagberg, H., Källander, C. F. R. and Simonsson, B. (1980) Optimized assay for thymidine kinase and its application for the detection of antibodies against herpes simplex virus type 1-and 2-induced thymidine kinase. Infect. Immun., 29, 425-434.
45. Kaplan, E. L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 157-181.
46. Cox, D. (1972) Regression model and life-tables (with discussion). J. R. Stat. Soc., 34, 187-220.
47. Rodriguez, J., Cabanillas, F., McLaughlin, P., Swan, F., Rodriguez, M., Hagemeister, F. and Romaguera, J. (1992) A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'. Ann. Oncol., 3, 711-717.
48. Langenmayer, I., Schlag, R., Hallek, M., Dietzfelbinger, H., Nehrl, C., Knauf, W., Maubach, P., Ziegler-Heitbrock, H. W. L., Thiel, E. and Emmerich, B. (1991) Interferon alpha 2b in the treatment of early stage CLL with risk for progression. First report of a randomized multicenter AIO study (abstr.). Ann. Hematol., 63, A98.
49. Knauf, W., Langenmayer, I., Nerl, C., Dietzfelbinger, H., Maubach, P., Ziegler-Heitbrock, H. W. L., Emmerich, B. and Thiel, E. (1992) Interferon-alpha2b for early phase chronic lymphocytic leukemia with high risk for progression-first results of a randomized multicenter AIO-study. Onkologie, 15, 55-7.
50. Rozman, C., Montserrat, E., Rodriguez-Fernandez, J. M., Ayats, R., Vallespi, T., Parodi, R., Rios, A., Prados, D., Morey, M., Gomis, F., Alcata, A., Gutierrez, M., Maldonado, J., Gonzalez, C., Giralt, M., Hernandez-Nieto, L., Cabrena, A. and Femandez-Ranada, J. M. (1984) Bone marrow histology pattern. The best single prognostic parameter in chronic lymphocytic leukemia. A multivariate analysis of 329 cases. Blood, 64, 642.
51. Geisler, C. H., Larson, J. K., Hansen, N. E., Hansen, M. M., Christensen, B. E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E. and Andersen, P. K. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78, 1795-1802.
52. Montserrat, E., Vinolas, N., Reverter, J. C. and Rozman, C. (1988) Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv. Rev. Fr. Hematol., 30, 359-361.
53. Abbas, A. K., Lichtman, A. H. and Pober, J. S. (1991) Molecular and cellular immunology. Philadelphia, W. B. Saunders Company.
54. Reichard, P. and Estborn, B. (1951) Utilization of deoxyribosides in the synthesis of polynucleotides. J. Biol. Chem., 188, 839-846.
55. Kit, S. (1979) Viral-associated and induced enzymes. Phamacol. Therapeut., 4, 501-585.
56. Bello, L. J. (1974) Regulation of thymidine kinase synthesis in human cells. Exp. Cell. Res., 89, 263-274.
57. Gronowitz, J. S., Källander, C. F. R., Diderholm, H., Hagberg, H. and Petterson, U. (1984) Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int. J. Cancer, 33, 5-12.
58. Pardee, A. B. (1989) G1 events and regulation of cell proliferation. Science, 246, 603-608.
59. Källander, C. F. R., Simonsson, B., Gronowitz, J. S. and Nilsson, K. (1987) Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia. Eur. J. Haematol., 38, 331-337.
60. Lehtinen, M., Wigren, T., Lehtinen, T., Kallioniemi, O. P., Aine, R., Aaran, R. K. and Ojala, A. (1988) Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer. Tumour Biol., 9, 287-92.
61. McKenna, P. G., O'Neill, K. L., Abram, W. P. and Hannigan, B. M. (1988) Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients. Br. J. Cancer, 57, 619-22.
62. Hallek, M., Wanders, L., Strohmeyer, S. and Emmerich, B. (1992) Thymidine kinase: a tumor marker with prognostic value for nonHodgkin's lymphoma and a broad range of potential clinical applications. Ann. Hematol., 65, 1-5.
63. Ellims, P. H. (1981) Thymidine kinase isozymes in chronic lymphocytic leukemia. Br. J. Haematol., 49, 479-481.